SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001654954-19-006937
Filing Date
2019-06-05
Accepted
2019-06-05 09:36:29
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-3 azrxs3_2019.htm S-3 338029
2 CONSENTS OF EXPERTS AND COUNSEL ex23-2.htm EX-23.2 3805
3 IMAGE azrxs3_july2018000.jpg GRAPHIC 5484
4 IMAGE azrxs3_july2018001.jpg GRAPHIC 7515
  Complete submission text file 0001654954-19-006937.txt   361092
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: S-3 | Act: 33 | File No.: 333-231954 | Film No.: 19878893
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1